{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:17:01Z","timestamp":1790165821101,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.psychres.2017.05.021","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T13:01:30Z","timestamp":1494939690000},"page":"78-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Adverse effects and treatment satisfaction among online users of four antidepressants"],"prefix":"10.1016","volume":"255","author":[{"given":"Shannon","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lacasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid Rogers","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Spaulding-Givens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2017.05.021_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000080392","article-title":"Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction","volume":"73","author":"Bolling","year":"2004","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.psychres.2017.05.021_bib2","series-title":"Statistical Power and Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.psychres.2017.05.021_bib3","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00213-014-3467-8","article-title":"Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals","volume":"231","author":"Crawford","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2017.05.021_bib4","unstructured":"CriticalThink Rx, 2009. The medication treatment emergent effects checklist.\u00a0\u3008http:\/\/criticalthinkrx.org\/pdf\/m7\/Module-7-Medication-Monitoring-Checklist.pdf\u3009."},{"key":"10.1016\/j.psychres.2017.05.021_bib5","first-page":"36","article-title":"Vortioxetine (Brintellix): a new serotonergic antidepressant","volume":"40","author":"D'Agostino","year":"2015","journal-title":"PT Drug Forecast"},{"key":"10.1016\/j.psychres.2017.05.021_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","article-title":"Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis","volume":"155","author":"Gartlehner","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.psychres.2017.05.021_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/157488611795684622","article-title":"The psychoactive effects of antidepressants and their association with suicidality","volume":"6","author":"Goldsmith","year":"2011","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.psychres.2017.05.021_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/sw\/55.2.105","article-title":"Understanding the assessment of psychotropic drug harms in clinical trials to improve social workers' role in medication monitoring","volume":"55","author":"Hughes","year":"2010","journal-title":"Soc. Work"},{"key":"10.1016\/j.psychres.2017.05.021_bib9","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2196\/jmir.1716","article-title":"Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the Internet","volume":"13","author":"Hughes","year":"2011","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.psychres.2017.05.021_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JRS-160723","article-title":"Adverse event assessment methods in published trials of psychotropic drugs: poor reporting and neglect of emerging safety concerns","volume":"28","author":"Hughes","year":"2016","journal-title":"Int. J. Risk Saf. Med."},{"key":"10.1016\/j.psychres.2017.05.021_bib11","series-title":"IBM SPSS Statistics for Windows, Version 24.0","author":"Corp","year":"2016"},{"key":"10.1016\/j.psychres.2017.05.021_bib12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.psychres.2017.05.021_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.285.4.437","article-title":"Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas","volume":"285","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2017.05.021_bib14","first-page":"27","article-title":"What is really known about psychological alterations produced by psychiatric drugs? Int","volume":"12","author":"Jacobs","year":"1999","journal-title":"J. Risk Saf. Med."},{"key":"10.1016\/j.psychres.2017.05.021_bib15","first-page":"17","article-title":"Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis","author":"Jakobsen","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.021_bib16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999\u20132012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2017.05.021_bib17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4088\/JCP.11r06984","article-title":"Vilazodone: clinical basis for the US food and drug administration's approval of a new antidepressant","volume":"72","author":"Laughren","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.021_bib18","doi-asserted-by":"crossref","first-page":"h4320","DOI":"10.1136\/bmj.h4320","article-title":"Restoring study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence","volume":"351","author":"Le Noury","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2017.05.021_bib19","unstructured":"Lundbeck Pharmaceuticals, 2016. Corporate release: solid sales performance in 2015 and return to profitability in 2016 \u3008http:\/\/investor.lundbeck.com\/releasedetail.cfm?ReleaseID=954188\u3009."},{"key":"10.1016\/j.psychres.2017.05.021_bib20","doi-asserted-by":"crossref","first-page":"b1963","DOI":"10.1136\/bmj.b1963","article-title":"How do psychiatric drugs work?","volume":"338","author":"Moncrieff","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2017.05.021_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0447.2009.01356.x","article-title":"The subjective experience of taking antipsychotic medication: a content analysis of Internet data","volume":"120","author":"Moncrieff","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.05.021_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/02791072.2013.845328","article-title":"The psychoactive effects of psychiatric medication: the elephant in the room","volume":"45","author":"Moncrieff","year":"2013","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.psychres.2017.05.021_bib23","unstructured":"Peladeau, N., 2013. QDA Miner, 4.1.22 ed. Provalis Research, Montreal."},{"key":"10.1016\/j.psychres.2017.05.021_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1192\/bjp.bp.108.051110","article-title":"Emotional side effects of selective serotonin reuptake inhibitors: qualitative study","volume":"195","author":"Price","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.021_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2014.01.042","article-title":"Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants","author":"Read","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.05.021_bib26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1017\/S1461145712001605","article-title":"Multi-modality: a new approach for the treatment of major depressive disorder","volume":"16","author":"Richelson","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2017.05.021_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.psychres.2017.05.021_bib28","first-page":"14","article-title":"SSRI-induced indifference","volume":"7","author":"Sansone","year":"2010","journal-title":"Psychiatry (Edgemont)"},{"key":"10.1016\/j.psychres.2017.05.021_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1192\/bjp.bp.108.061960","article-title":"Adverse reactions to antidepressants","volume":"195","author":"Uher","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.021_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10871200214752","article-title":"Communicating judgments about practical significance: effect size, confidence intervals and odds ratios","volume":"7","author":"Vaske","year":"2002","journal-title":"Hum. Dimens. Wildl."},{"key":"10.1016\/j.psychres.2017.05.021_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13651501.2013.794245","article-title":"A review of current evidence for vilazodone in major depressive disorder","volume":"17","author":"Wang","year":"2013","journal-title":"Int. J. Psychiatry Clin. Pract."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116321874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116321874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T16:31:12Z","timestamp":1535819472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116321874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":31,"alternative-id":["S0165178116321874"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.05.021","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse effects and treatment satisfaction among online users of four antidepressants","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}